1 Market Overview: Understanding the Global Sumatriptan Landscape The ​global sumatriptan market​ continues to demonstrate robust growth, with the injectable formulation segment alone projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.2% . This expansion is primarily driven by the ​increasing prevalence of migraine disorders​ worldwide, which affect approximately 15% of the global population according to the World Health Organization . Sumatriptan, as a selective serotonin receptor agonist, has established itself as a ​first-line treatment​ for acute migraine attacks due to its rapid effectiveness and relatively favorable safety profile . The market dynamics for sumatriptan are characterized by distinct regional variations…